2. Academic Validation
  3. Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity

Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity

  • Int Immunopharmacol. 2025 Jul 14:163:115209. doi: 10.1016/j.intimp.2025.115209.
Shengwei Chen 1,  Lizhuowen Yan 2,  Jingtao Zeng 2,  Wei Meng 2,  Jionghan Zhuang 2,  Fengying Chen 3,  Yonglong Guo 2,  A M Abd El-Aty 4,  Xianghong Ju 3,  Shihua Yang 5
Affiliations

Affiliations

  • 1 College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China; Shenzhen Institute of Guangdong Ocean University, Organization X, Shenzheng 518000, China; College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang 524088, China.
  • 2 College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
  • 3 Shenzhen Institute of Guangdong Ocean University, Organization X, Shenzheng 518000, China; College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang 524088, China.
  • 4 Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt; Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum 25240, Turkey.
  • 5 College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: yangsh@scau.edu.cn.
PMID: 40663810 DOI: 10.1016/j.intimp.2025.115209
Abstract

D-Cycloserine (DCS), a broad-spectrum Antibiotic and NMDA Receptor Modulator, exhibits immunomodulatory effects beyond its known neurological and antimicrobial functions. This study investigated DCS's therapeutic potential in inflammatory bowel disease (IBD) and colitis-associated colorectal Cancer (CAC) using in vitro and in vivo models. In lipopolysaccharide (LPS)-stimulated NCM460 cells, DCS inhibited NLRP3 inflammasome activation and restored tight junction protein expression. In dextran sulfate sodium (DSS)-induced murine colitis, both preventive and therapeutic DCS regimens attenuated inflammation, reduced histopathological damage, and preserved intestinal barrier integrity. In azoxymethane (AOM)/DSS-induced CAC, DCS decreased tumor burden and reduced Ki-67+ cell proliferation without systemic toxicity. These findings position DCS as a promising dual-target candidate for IBD and CAC management through NLRP3-caspase-1-GSDMD pathway inhibition and epithelial barrier maintenance.

Keywords

CAC; D-cycloserine; IBD; NLRP3-caspase1-GSDMD; Tight junction proteins.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z